Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
FDA Office of Orphan Products Development
Children's Hospital of Philadelphia

      The goal of this application is to evaluate the safety and efficacy of atorvastatin as a
      potential treatment to preserve beta cell function in children and young adults with newly
      diagnosed type 1 diabetes (T1DM).
    
Drug